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Giant vascular eccrine spiradenomas (GVESs) are a rare 
variant of the eccrine spiradenoma that develops from the 
sweat gland. It is different from the eccrine spiradenoma in 
its larger size and greater degree of vascularity. Bleeding 
and/or ulceration are common clinical features of this tumor, 
and are the reason why it is often clinically confused with a 
vascular or malignant tumor. Here, a rare case of GVES 
without bleeding or ulceration is reported. (Ann Dermatol 
23(S2) S197∼S200, 2011)
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INTRODUCTION
Giant vascular eccrine spiradenoma (GVES) is a variant of 
an eccrine spiradenoma. GVES is very rare and differs 
from the eccrine spiradenoma in its larger size clinically 
and marked vascularity histopathologically. GVES is usu-
ally accompanied by bleeding and/or ulceration, and of-
ten misdiagnosed as a vascular or malignant tumor clin-
ically
1.
Here, we report a case of GVES. The lesion presented as a 
slightly bluish mass and the overlying skin of the lesion 
was intact without erosion, ulceration, or hemorrhage. 
The diagnosis of GVES was made via histopathological 
examination.
CASE REPORT
A 49-year-old woman presented with a solitary deep mass 
of 10-year duration on the right upper arm. The lesion was 
asymptomatic, firm, and 2.5×2.5 cm in size, with a bluish 
color in the overlying intact skin (Fig. 1). On physical ex-
amination, there were no abnormal findings other than the 
cutaneous lesion. An excisional biopsy was performed 
and the specimen was grossly hemorrhagic. The histo-
pathological findings of the lesion showed a large, 
well-circumscribed, encapsulated, multilobulated tumor in 
the dermis. There was extensive hemorrhage and numer-
ous dilated vascular spaces containing red blood cells or 
pale pinkish lymph fluid in the tumor (Fig. 2A). The lo-
bules were composed of two different types of cells form-
ing cords, bands, or pseudoglandular rosettes: cells with 
small, dark nuclei at the periphery and cells with large 
pale nuclei in the center of the lobules (Fig. 2B). 
Immunohistochemically, the tumor cells were positive for 
cytokeratin (CK), epithelial membrane antigen (EMA), 
S-100, smooth muscle actin (SMA), and p63 (Fig. 3). They 
were negative for carcinoembryonic antigen (CEA), CD15, MH Kim, et al
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Fig. 2. (A) Well-demarcated, encapsulated, multilobulated tumor in the dermis with many blood-filled vessels and extensive hemorrhage
(H&E, ×25). (B) The tumor was composed of two types of cells: cells with small, dark nuclei at the periphery of the lobules and 
cells with large, pale nuclei in the center of the lobules (H&E, ×200).
Fig. 3. Immunohistochemical staining for CK (A: ×100), EMA (B: ×100), S-100 (C: ×100), SMA (D: ×100), and p63 (E: ×100).
CK: cytokeratin, EMA: epithelial membrane antigen, SMA: smooth muscle actin.
gross cystic disease fluid protein-15, and lysozyme. The 
lesion was removed completely with an excisional biopsy 
and no recurrence has occurred for six months following 
the procedure.
DISCUSSION
GVES is a rare variant of eccrine spiradenoma and was 
first described by Cotton et al.
1 in 1986. Eccrine spi-
radenoma usually presents as a solitary, reddish-brown, 
sometimes painful, deep nodule measuring 1 to 2 cm in 
diameter
2,3. GVES is different from eccrine spiradenoma in 
that it is larger than the eccrine spiradenoma clinically, 
and has a marked degree of vascularity histopathologi-
cally. In the English literature, there are only six cases of 
GVES (Table 1)
1,4-7. All previously reported cases of GVES, 
including this case, were in adults or the elderly, and had 
a large lesion of more than 2 cm in size. The locations 
were variable in each case and included the abdomen, 
back of scalp, costochondral line, lower back, and Giant Vascular Eccrine Spiradenoma
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Table 1. Clinical features of patients with giant vascular eccrine spiradenoma in the English literature
Reference Age/Sex Size (cm) Location Clinical diagnosis
Cotton et al.
1 74/M 5 Abdomen Angiosarcoma or malignant melanoma
84/F 2 Back of scalp Sebaceous cyst
Hey et al.
4 63/F 3.5×1.5 Right thigh Venous thrombosis
Senol et al.
5 60/M 3∼4 Right costochondral line Angiomatous lesion or thrombosis
Ko et al.
6 56/F 2 Right lower back Angiolipoma or neuroma
Yamakoshi et al.
7 76/M 5×3.4×2.6 Right shoulder Not mentioned
Present case 49/F 2.5×2.5 Right upper arm Vascular tumor or venous malformation
M: male, F: female.
shoulder.
Bleeding and ulceration are common clinical features of 
GVES. Therefore, GVES may result in misdiagnosis of an-
giomatous lesion or malignant neoplasm. Among pre-
viously reported cases of GVES, the lesions in four cases 
showed bleeding or ulceration
1,5,7. The lesions had been 
misdiagnosed clinically as vascular lesion or malignancy 
with diagnoses such as angiosarcoma, malignant melano-
ma, and thrombosis. Compared with other cases, this case 
had a distinctive clinical appearance of a slightly bluish 
color with no bleeding or ulceration.
The histopathological features of GVES are similar to those 
of eccrine spiradenoma. Eccrine spiradenoma consists of 
several lobules located in the dermis without connections 
to the epidermis. The lobules are sharply demarcated and 
encapsulated with fibrous tissue. Two types of cells are 
present in the tumor. One cell type has small, dark nuclei, 
and is located at the periphery of the lobules. The other 
cell type has large, pale nuclei, and is located in the cen-
ter of the lobules. These cells are arranged in anastomos-
ing cords and bands or pseudoglandular rosettes
3. In addi-
tion, GVES has characteristic histopathological features. It 
has a large number of wide vessels filled with red blood 
cells or lymph fluid in the stroma and an extensive hemor-
rhagic appearance
6.
Eccrine spiradenoma is thought to originate from eccrine 
sweat glands. By immunohistochemistry, the tumor cells 
of eccrine spiradenoma express CK, CEA, EMA, and my-
oepithelial differentiation and is identified by positive 
staining for SMA and S-100
8-10. Immunohistochemical 
study of the GVES shows a large lumen and pale epithelial 
cells positive for CK, CK7, Cam5.2, and EMA. In addition, 
the outer layer of the small basaloid cells are positive for 
p63, and many p63+/SMA+ myoepithelial cells are pres-
ent
6. Therefore, eccrine spiradenoma has been regarded 
as a tumor differentiating mainly to the secretory portion 
of the secretory coil of eccrine sweat glands. In the present 
case, the CK, EMA, and S-100 were positive in the tumor 
cells and the CEA was weakly positive only in the luminal 
secretions which is consistent with prior reports. 
However, there are several lines of evidence that suggest 
that eccrine spiradenoma is a neoplasm of apocrine line-
age rather than eccrine origin. First, eccrine spiradenoma 
can be accompanied by cylindroma or trichoblastoma 
which are tumors of apocrine or folliculosebaceous-apoc-
rine origin. Second, eccrine spiradenoma usually occurs 
where apocrine elements are rich, such as breast, axilla, 
genitalia, and ear. Third, eccrine spiradenoma occasion-
ally presents the histopathological features of decapitation 
secretion
11.
GVES is rare and easily mistaken for vascular or malignant 
tumors because of its hemorrhagic and/or ulcerative 
tendencies. Here, we describe a case of GVES with a blu-
ish deep mass and no hemorrhage or ulceration.
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